Morgan Lewis Ranks Among Top Life Sciences M&A Firms in Second Quarter

WASHINGTON, D.C., August 19, 2010: Morgan Lewis placed highly among global law firms in BioPharm Insight’s second quarter licensing and mergers and acquisitions rankings. The firm’s accomplishments include:

• Ranked third, global legal adviser to licensing agreements based on value (at $690M)
• Ranked fifth, global legal adviser to licensing agreements based on volume with two deals
• Ranked 13th, legal adviser North American mergers and acquisitions based on volume with three deals
• Ranked 20th, legal adviser to European mergers and acquisitions based on volume with three deals